Pentachlorocyclopentadiene (CASRN 25329-35-5)
view QuickView

0431
Pentachlorocyclopentadiene; CASRN 25329-35-5
Health assessment information on a chemical substance is included in IRIS only after a comprehensive review of chronic toxicity data by U.S. EPA health scientists from several Program Offices and the Office of Research and Development. The summaries presented in Sections I and II represent a consensus reached in the review process. Background information and explanations of the methods used to derive the values given in IRIS are provided in the Background Documents.
STATUS OF DATA FOR Pentachlorocyclopentadiene
File First On-Line 03/01/1990
Category (section) |
Status |
Last Revised |
---|---|---|
Oral RfD Assessment (I.A.) | no data | |
Inhalation RfC Assessment (I.B.) | no data | |
Carcinogenicity Assessment (II.) | on-line | 03/01/1990* |
*A comprehensive review of toxicological studies was completed (07/27/05) - please see section II.D.2. for more information.
_I. Chronic Health Hazard Assessments for Noncarcinogenic Effects
_I.A. Reference Dose for Chronic Oral Exposure (RfD)
Substance Name — Pentachlorocyclopentadiene
CASRN — 25329-35-5
Not available at this time.
_I.B. Reference Concentration for Chronic Inhalation Exposure (RfC)
Substance Name — Pentachlorocyclopentadiene
CASRN — 25329-35-5
Not available at this time.
_II. Carcinogenicity Assessment for Lifetime Exposure
Substance Name — Pentachlorocyclopentadiene
CASRN — 25329-35-5
Last Revised — 03/01/1990
Section II provides information on three aspects of the carcinogenic assessment for the substance in question; the weight-of-evidence judgment of the likelihood that the substance is a human carcinogen, and quantitative estimates of risk from oral exposure and from inhalation exposure. The quantitative risk estimates are presented in three ways. The slope factor is the result of application of a low-dose extrapolation procedure and is presented as the risk per (mg/kg)/day. The unit risk is the quantitative estimate in terms of either risk per ug/L drinking water or risk per ug/cu.m air breathed. The third form in which risk is presented is a drinking water or air concentration providing cancer risks of 1 in 10,000, 1 in 100,000 or 1 in 1,000,000. The rationale and methods used to develop the carcinogenicity information in IRIS are described in The Risk Assessment Guidelines of 1986 (EPA/600/8-87/045) and in the IRIS Background Document. IRIS summaries developed since the publication of EPA's more recent Proposed Guidelines for Carcinogen Risk Assessment also utilize those Guidelines where indicated (Federal Register 61(79):17960-18011, April 23, 1996). Users are referred to Section I of this IRIS file for information on long-term toxic effects other than carcinogenicity.
_II.A. Evidence for Human Carcinogenicity
__II.A.1. Weight-of-Evidence Characterization
Classification — D; not classifiable as to human carcinogenicity
Basis — Lack of data concerning carcinogenicity to humans or animals.
__II.A.2. Human Carcinogenicity Data
None.
__II.A.3. Animal Carcinogenicity Data
None.
__II.A.4. Supporting Data for Carcinogenicity
Mutagenicity was observed for Escherichia coli k12 at 24E-6 to 24E-4 M with but not without mouse hepatic homogenates (Goggelmann et al., 1978).
_II.B. Quantitative Estimate of Carcinogenic Risk from Oral Exposure
None.
_II.C. Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure
None
_II.D. EPA Documentation, Review, and Contacts (Carcinogenicity Assessment)
__II.D.1. EPA Documentation
Source Document — U.S. EPA, 1988
The 1988 Health and Environmental Effects document has received Agency Review.
__II.D.2. EPA Review (Carcinogenicity Assessment)
Agency Work Group Review — 10/05/1989
Verification Date — 10/05/1989
A comprehensive review of toxicological studies published through July 2005 was conducted. No new health effects data were identified that would be directly useful in the revision of the existing carcinogenicity assessment for Pentachlorocyclopentadiene and a change in the assessment is not warranted at this time. For more information, IRIS users may contact the IRIS Hotline at hotline.iris@epa.gov or (202)566-1676.
__II.D.3. EPA Contacts (Carcinogenicity Assessment)
Please contact the IRIS Hotline for all questions concerning this assessment or IRIS, in general, at (202)566-1676 (phone), (202)566-1749 (FAX) or hotline.iris@epa.gov (internet address).
_III.
[reserved]
_IV. [reserved]
_V. [reserved]
_VI. Bibliography
Substance Name — Pentachlorocyclopentadiene
CASRN — 25329-35-5
Last Revised — 03/01/1990
_VI.A. Oral RfD References
None
_VI.B. Inhalation RfD References
None
_VI.C. Carcinogenicity Assessment References
Goggelmann, W., G. Bonse, D. Henschler and H. Greim. 1978. Mutagenicity of chlorinated cyclopentadiene due to metabolic activation. Biochem. Pharmacol. 27: 2927-2929.
U.S. EPA. 1988. Health and Environmental Effects Document for Chlorinated Cyclopentadienes. Prepared by the Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office, Cincinnati, OH for the Office of Solid Waste and Emergency Response, Washington, DC.
_VII. Revision History
Substance Name — Pentachlorocyclopentadiene
CASRN — 25329-35-5
Date |
Section |
Description |
---|---|---|
03/01/1990 | II. | Carcinogen assessment on-line |
03/01/1990 | VI. | Bibliography on-line |
04/01/1997 | III., IV., V. | Drinking Water Health Advisories, EPA Regulatory Actions, and Supplementary Data were removed from IRIS on or before April 1997. IRIS users were directed to the appropriate EPA Program Offices for this information. |
12/03/2002 | II.D.2. | Screening-Level Literature Review Findings message has been added. |
08/15/2005 | II.D.2. | Screening-Level Literature Review Findings message has been removed and replaced by comprehensive literature review conclusions. |
_VIII. Synonyms
Substance Name — Pentachlorocyclopentadiene
CASRN — 25329-35-5
Last Revised — 03/01/1990
- 25329-35-5
- 1,3-Cyclopentadiene, 1,2,3,4,5-pentachloro-
- Cyclopentadiene, 1,2,3,4,5-pentachloro-
- Pentachlorocyclopentadiene
- 1,2,3,4,5-PENTACHLOROCYCLOPENTADIENE